Transforming cancer's faintest traces into medicine's most powerful tools
Freenome is changing the way the world looks at cancer by decoding the vast complexity of the cell-free genome – where breakthroughs in artificial intelligence turn hidden patterns into tools for early detection, and novel pathways are revealing new and better ways to treat.
Blood tests for cancer screening
oncology, and drug development
Accurate and accessible screening tests to detect cancer early, before symptoms occur.
Solving unmet needs in precision oncology and immuno-oncology with accurate companion diagnostics.
Working with academic and pharmaceutical partners to identify new therapeutic targets.
Lifesaving early cancer detection
For the 8 most common cancers, starting eﬀective treatment during stage 1
or 2 has demonstrated 10-year survival rates of 80% to 90%. Unfortunately,
current screening approaches often fail to detect cancer until signiﬁcant
progression has already occurred.
Optimizing cancer treatment
In addition to early cancer screening, classifying the billions of patterns that
deﬁne each tumor type can help oncologists predict which therapy is likely
to work best. Over time, the data we collect is revealing new targets for the
next-generation of cancer therapies.